Navigation Links
Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer

Breast cancer is the most common type of cancer among women. Despite the awareness programmes and the massive screening strategies, it has not possible to eliminate the fear associated with the disease. Mammography is one of the routine tests // used in the early identification of the disease.

However, a new study finds the number of women getting routine screening mammography may be less than previously reported. As many as one in three women have never had a mammogram or have not had one in more than two years. Furthermore, many women who have had one or two mammograms failed to return for regular screenings.

While screening mammography has been credited with significant improvements in breast cancer outcomes, the success of campaigns to increase screening use have not shown consistent improvements.

In New Hampshire studies assessing use demonstrate that overall use by women 50 years old and older range from 65-82 percent and depend on age. However, these studies rely on self-reporting surveys prone to poor patient recall or single community healthcare facility use.

The researchers found 36 percent of women 40 and over in New Hampshire had either never had a mammogram or had not had one in over 27 months. Older women over 80 years old were more likely than younger women to not receive screening.

Among those women who had received screening in their lifetime, only 65 percent received routine screening within the recommended one to two year interval. The remaining 35 percent had one or two screening mammograms and did not return with 27 months.

The figures only address the need for a critical evaluation regarding the issue as to why women fail to report. An initiative by the breast cancer registry to follow up patients on a long-term basis would be appropriate.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ODH, Inc.™ ... Care Summit, February 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s ... PerformCARE to use behavioral health analytics to improve Medicaid population health management. , ODH ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... newly designed TaskMate Go. Core benefits and advantages built into the home office ... stylish, functional look and feel. Ability to gain the benefits embedded in the ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis ... University of Pittsburgh points to eight genes that may explain why susceptibility to one ... the results of a study published today in the journal npj Schizophrenia. , ...
(Date:2/24/2017)... ... 2017 , ... With millions of Americans and people worldwide ... all are aware of our options and are empowered with strength and information ... of its newest edition of "Vision and Hearing" in USA Today, that will ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University Institute for Palliative ... in or interested in palliative care education and research. The Symposium, “Innovate. Investigate. ... County San Diego on Sept. 28 and 29, 2017, on the campus of California ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... -- Genesis Healthcare Services has merged with Hospice Cloud, a ... Bill Monast , President and CEO of Hospice Cloud ... , executives with Home Health Depot, Inc., the parent ... This acquisition helps Hospice Cloud maintain its position as ... equipment (DME) solutions for the hospice industry. Nathan ...
Breaking Medicine Technology: